Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 1
2013 1
2014 1
2015 1
2016 3
2018 3
2019 2
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Abacavir-induced liver toxicity.
Pezzani MD, Resnati C, Di Cristo V, Riva A, Gervasoni C. Pezzani MD, et al. Among authors: di cristo v. Braz J Infect Dis. 2016 Sep-Oct;20(5):502-4. doi: 10.1016/j.bjid.2016.03.002. Epub 2016 Apr 4. Braz J Infect Dis. 2016. PMID: 27054757 Free PMC article. Review.
Gastrointestinal basidiobolomycosis: An emerging mycosis difficult to diagnose but curable. Case report and review of the literature.
Pezzani MD, Di Cristo V, Parravicini C, Sonzogni A, Tonello C, Franzetti M, Sollima S, Corbellino M, Galli M, Milazzo L, Antinori S. Pezzani MD, et al. Among authors: di cristo v. Travel Med Infect Dis. 2019 Sep-Oct;31:101378. doi: 10.1016/j.tmaid.2019.01.013. Epub 2019 Jan 17. Travel Med Infect Dis. 2019. PMID: 30660554 Free article. Review.
Orlistat: weight lost at cost of HIV rebound.
Gervasoni C, Cattaneo D, Di Cristo V, Castoldi S, Gervasi E, Clementi E, Riva A. Gervasoni C, et al. Among authors: di cristo v. J Antimicrob Chemother. 2016 Jun;71(6):1739-41. doi: 10.1093/jac/dkw033. Epub 2016 Mar 5. J Antimicrob Chemother. 2016. PMID: 26945709 No abstract available.
Lipid-lowering effect of tenofovir in HIV-infected patients.
Fabbiani M, Bracciale L, Doino M, Sidella L, Farina S, Di Cristo V, Cauda R, De Luca A, Di Giambenedetto S. Fabbiani M, et al. Among authors: di cristo v. J Antimicrob Chemother. 2011 Mar;66(3):682-3. doi: 10.1093/jac/dkq464. Epub 2010 Dec 5. J Antimicrob Chemother. 2011. PMID: 21131692 No abstract available.
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression.
Antinori A, Cossu MV, Menzaghi B, Sterrantino G, Squillace N, Di Cristo V, Cattelan A, Focà E, Castagna A, Orofino G, Valenti D, D'Ettore G, Aprea L, Ferrara S, Locatelli ME, Madeddu G, Pontali E, Scerbo P, Rossetti B, Uglietti A, Termini R, Rucci F, Gori A, Mancusi D. Antinori A, et al. Among authors: di cristo v. Patient. 2020 Jun;13(3):375-387. doi: 10.1007/s40271-020-00413-y. Patient. 2020. PMID: 32266663 Free PMC article.
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation.
Di Cristo V, Adorni F, Maserati R, Annovazzi Lodi M, Bruno G, Maggi P, Volpe A, Vitiello P, Abeli C, Bonora S, Ferrara M, Cossu MV, Oreni ML, Colella E, Rusconi S. Di Cristo V, et al. HIV Res Clin Pract. 2020 Feb;21(1):34-43. doi: 10.1080/25787489.2020.1734752. Epub 2020 Mar 4. HIV Res Clin Pract. 2020. PMID: 32129161 Clinical Trial.
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience.
Vitiello P, Taramasso L, Ricci E, Maggi P, Martinelli C, Gabrielli C, Vittorio De Socio G, Di Cristo V, Rusconi S, Falasca K, Menzaghi B, Tebini A, Di Biagio A. Vitiello P, et al. Among authors: di cristo v. J Women Aging. 2019 Mar-Apr;31(2):176-188. doi: 10.1080/08952841.2018.1428100. Epub 2018 Jan 25. J Women Aging. 2019. PMID: 29369016
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group. Fabbiani M, et al. J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123. J Antimicrob Chemother. 2018. PMID: 29668978 Clinical Trial.
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression.
Antinori A, Cossu MV, Menzaghi B, Sterrantino G, Squillace N, Di Cristo V, Cattelan A, Focà E, Castagna A, Orofino G, Valenti D, D'Ettore G, Aprea L, Ferrara S, Locatelli ME, Madeddu G, Pontali E, Scerbo P, Rossetti B, Uglietti A, Termini R, Rucci F, Gori A, Mancusi D. Antinori A, et al. Among authors: di cristo v. Patient. 2020 Aug;13(4):469-470. doi: 10.1007/s40271-020-00425-8. Patient. 2020. PMID: 32468416 Free PMC article.
16 results